JCNRJournal of Clinical and Nursing Research2208-36852208-3693Bio-Byword Scientific Publishing Pty. Ltd.10.26689/jcnr.v9i9.11681ArticlePractice and Exploration of Target Management Model for Clinical Pharmacists in Primary Hospitalshttps://artdesignp.com/journal/JCNR/9/9/10.26689/jcnr.v9i9.11681ZhanXia,ZhouTing,BaoHongrong2025992025-10-22Objective To explore the target management model for clinical pharmacists in primary hospitals facing current shortages of clinical pharmacists, in order to improve the work efficiency and service quality of clinical pharmacy, and promote the high-quality development of clinical pharmacy in primary hospitals. Methods Developing a target management model, adopting a wide coverage work model of "1+1+N" (that is, 1 clinical pharmacist, 1 resident clinical department and N contracted clinical departments). According to the SMART principle, various work assessment indicators were quantified. This involved setting clear work goals, diversifying work methods, personalizing work methods, standardizing workflows, and using numerical assessment indicators. Regular supervision, inspection, feedback, and improvement mechanisms were implemented. Results The implementation of the target management model has made the work effectiveness of clinical pharmacists visualized. There were more than 200 annual consultations and multidisciplinary team (MDT) cases, with an opinion adoption rate of 90.2% and a patient improvement rate of 80.6%. More than 1500 rational drug use interventions were conducted, with a suggestion adoption rate of 83.5%. In terms of pharmaceutical indicators control. The intensity of antibacterial drug use in 2024 (without CMI adjustment) was 30.07 DDDs, significantly lower than the 2023 value of 33.54 DDDs, and also significantly lower than the provincial average (32.87 DDDs) and the average for hospitals of the same level (32.49 DDDs). The daily usage of intravenous infusion per bed for hospitalized patients was 2.09, a decrease from 2.15 in 2023, significantly lower than the provincial average of 2.71 and the average of 2.56 in hospitals of the same level. The amount of the second batch of national key monitoring drugs accounts for the value was 6.48%, significantly lower than the provincial average of 8.27% and the same level hospital average of 8.82%. In terms of chronic disease pharmaceutical management, taking the pharmaceutical management of patients with chronic heart failure as an example, the usage rates of RA inhibitors and β-blockers for heart failure in the management group were 87.88% and 80.81%, respectively, significantly higher than those in the control group (62.22% and 65.56%). Heart rate in the management group (69.54 ± 10.68 times·min-1 ) was significantly lower than in the control group (80.04 ± 17.68 times·min-1 ) (P<0.001). The low-density lipoprotein (1.69 ± 0.57 mmol·L-1) was significantly lower than the control group (1.95 ± 0.77 mmol·L-1) (P<0.001), and the 1-year readmission rate was 47.47%, significantly lower than the control group 56.67%. The Minnesota Quality of Life Score was (44.20 ± 10.78), significantly lower than the control group (55.89 ± 11.48) (P<0.001), indicating a significant improvement in the patient's quality of life. Conclusions The targeted management model for clinical pharmacists can effectively enhance communication and collaboration between clinical pharmacists and clinicians, improve the work efficiency and service quality of clinical pharmacists in primary hospitals, promote the work of clinical pharmacy towards standardization and scientificization, boost the high-quality development of pharmacy in primary hospitals, and also provide new ideas and methods for the management of clinical pharmacists in other primary hospitals.

General Office of the National Health and Family Planning Commission, Office of the National Administration of Traditional Chinese Medicine, 2017, Notice on Strengthening Pharmaceutical Administration and Transforming Pharmaceutical Service Models, viewed on June 10, 2025.

Medical Administration Bureau of the National Health Commission, 2018, Opinions on Accelerating the High-Quality Development of Pharmaceutical Services, viewed on July 2, 2025.

Wu Y, Zhang Y, Shen Z, 2023, Research and Practice of Innovative Training Models for Clinical Pharmacist Talents. Chinese Journal of Medical Education Research, 22(2): 289–292.

Ou H, Zhou J, Yuan Z, 2020, Discussion on the Participation of Clinical Pharmacists in Chronic Disease Medication Management Models in Primary Hospitals. Medical Frontiers, 10(12): 235–237.

Liu C, Zhang Y, Chen D, et al., 2018, Construction of Quality Standards and Evaluation Index System for Pharmaceutical Services Provided by Clinical Pharmacists in Primary Hospitals. Modern Hospital Management, 16(6): 10–11.

Deng J, 2024, Analysis of the Value of Pharmaceutical Services in Promoting Rational Drug Use in Clinical Settings in Primary Hospitals. Family Pharmacist, 17(11): 128–130.

Yuan D, 2023, Key Points and Dilemmas of Clinical Pharmacy Work in Primary Hospitals. Medicine and Health, 7: 74–77.

Yuan D, 2023, Problems and Countermeasures in Clinical Pharmacy Work Under the Background of New Medical Reform. Medicine, 7: 14–17.

Chen M, Yan J, Tang K, et al., 2024, Refined Practice and Exploration of Pharmaceutical Administration in Large Public Hospitals. Chinese Journal of Clinical Pharmacy, 33(6): 408–412.

Song Z, Zhao R, Chen Y, et al., 2024, Construction and Practice of a “Practice-Research Integration” Model for Clinical Pharmacy Based on the Development and Implementation of High-Quality Evidence-Based Medication Guidelines. Chinese Journal of Clinical Pharmacy, 33(6): 401–407.

Xue Z, Chen H, Zheng F, et al., 2023, Construction and Practice of an Information-Based Training Model for Clinical Pharmacists. Chinese Journal of Health Informatics and Management, 20(5): 761–767.

Lin B, Fan W, Wang Y, et al., 2023, Practice and Exploration of Clinical Pharmacy Discipline Construction in County-Level Hospitals. Herald of Medicine, 42(5): 669–672.